According to DPI developer Iconovo, TOA Pharmaceutical has signed a new agreement for the use of an Iconovo dry powder inhaler for a feasibility study. TOA will pay €202,000 over the next year for use of the device in a development project for a generic aimed at the Japanese market. Iconovo did not specify which of its devices will be used in this new feasibility … [Read more...] about TOA Pharmaceutical extends its agreement with Iconovo
Products and Services
Akari Therapeutics chooses Inhalation Sciences for PK study of inhaled Nomacopan
According to Inhalation Sciences (ISAB), Akari Therapeutics has chosen ISAB's CRO, Inhalation Research Services, to conduct a pharmacokinetic study of Akari's Nomacopan, a C5 and LTB4 inhibitor that the company is evaluating as an inhaled therapy for the treatment of exacerbations in COPD and asthma. The PK study will be conducted using an isolated perfused lung (IPL) … [Read more...] about Akari Therapeutics chooses Inhalation Sciences for PK study of inhaled Nomacopan
Hovione to increase global capacity by 25%
CDMO Hovione said that it is investing $170 million to increase overall capacity at its manufacturing facilities in Portugal, Ireland, and the US by about 25% to meet strong demand. According to the company, its facilities expansion coincides with the addition of about 300 positions to its workforce. Hovione, which offers a full range of development and manufacturing … [Read more...] about Hovione to increase global capacity by 25%
Copley Scientific launches new nasal dose uniformity sampling apparatus interface
Inhaler testing equipment company Copley Scientific is introducing a new nasal dose uniformity sampling apparatus (DUSA) interface plate designed to work with the company's Vertus II/Plus shake and fire system for delivered dose uniformity testing of nasal products per Ph. Eur. 1 Chapter 0676 and USP Chapter <601>2. Earlier this year, the company announced the … [Read more...] about Copley Scientific launches new nasal dose uniformity sampling apparatus interface
Nemera launches UniSpray device for nasal delivery of systemic drugs
Device company Nemera has announced the launch of a new single metered dose nasal pump called UniSpray, which is designed for delivery of systemic drugs. According to the company, UniSpray requires no priming, is compatible with standard containers, and can be used at any angle. According to the announcement, UniSpray is a "concept under development," and the … [Read more...] about Nemera launches UniSpray device for nasal delivery of systemic drugs
Inhalation Sciences gets extension of XposeALI patent
According to Inhalation Sciences (ISAB), a US patent covering the XposeALI in vitro cell culturing module has been extended until 2034. US Patent No. 11054414 ("Exposure system") was originally filed in 2013, the company said. The patent is now expected to expire in 2034. The module, which works with the company's PreciseInhale dry powder aerosol testing system, … [Read more...] about Inhalation Sciences gets extension of XposeALI patent
Aptar Pharma to co-develop i2c’s Respitab MDI technology
Aptar Pharma will co-develop and promote i2c Pharmaceutical Services' Respitab MDI technology, the two companies have announced. The Respitab system involves formulating the drug as a tablet that can be easily dispensed into an MDI canister; the tablet is then dissolved or dispersed when the can is filled with propellant. According to the announcement, Aptar will … [Read more...] about Aptar Pharma to co-develop i2c’s Respitab MDI technology
Biosidus partners with Crystec on development of dry powder teriparatide for the treatment of osteoporosis
Argentinian pharma company Biosidus and Crystec have announced a new deal for development of dry powder formulations of Biosidus drugs for inhaled and/or nasal delivery using Crystec's mSAS supercritical fluid particle engineering technology. The first project for the two companies under the new agreement will be development of a dry powder formulation of teriparatide … [Read more...] about Biosidus partners with Crystec on development of dry powder teriparatide for the treatment of osteoporosis
Pulmodyne partners with Alcove on manufacturing and distribution of the EZ-Spray atomization system
Pulmodyne and Alcove Manufacturing and Distribution have announced a new partnership for manufacturing and distribution of Alcove's EZ-Spray intranasal mucosal atomization device and said that Pulmodyne is set to begin manufacturing and distributing EZ-Spray devices by the end of 2021. The two companies also said that they also intend to develop new atomization … [Read more...] about Pulmodyne partners with Alcove on manufacturing and distribution of the EZ-Spray atomization system
BreatheSuite MDI monitoring system gets 510(k) clearance
BreatheSuite announced that the FDA has cleared the company's disposable BreatheSuite MDI device, which attaches to the top of a standard metered dose inhaler canister to provide inhaler usage monitoring and feedback to the patient and to health care providers through an associated mobile app. According to BreatheSuite, the device has also been cleared by Canadian … [Read more...] about BreatheSuite MDI monitoring system gets 510(k) clearance